General Annual Meeting (GAM)
This folder contains all the recordings of the GAM.
Satellite 1 – Amgen: MRD matters: changing the paradigm for hematological malignancies
38th General Annual Meeting of the Belgian Hematology Society - Day 1 - Session III: Satellite 1 – Amgen: MRD matters: changing the paradigm for hematological malignancies
Advances in Laboratory Technology
38th General Annual Meeting of the Belgian Hematology Society - Day 1 - Session II: Advances in Laboratory Technology
Highlight 1
38th General Annual Meeting of the Belgian Hematology Society - Day 1 - Session I : Highlight 1
PACE, SAFYHR & Gilead Awards
Dominiek Mazure
Marc André
Philippe Lewalle
Closure
Ann Janssens, BHS President
Satellite 3 – Janssen : Healthcare anywhere? How a pandemic accelerated innovations optimizing disease management & patient care beyond hospital walls
Chair: Ann Janssens
Keynote session: Bringing care to the patient, anywhere, anytime
Koen Kas, UZ Gent, Belgium
Panel discussion: Home care today, home care of the future
Annemarie Coolbrandt, UZ Leuven, Belgium
Pascale Frère, CHR Verviers, Belgium
Walter Van Dyck, Vlerick Business School, Belgium
Koen Van Eygen, AZ Groeninge Kortrijk, Belgium
Koen Kas, UZ Gent, Belgium
Highlight on novel cellular therapies
Chairs: Koen Theunissen & Philippe Lewalle
CAR T-cells experience in Belgium
Sophie Servais, CHU Liège, Belgium
Barbara De Moerloose, UZ Gent, Belgium
Redirecting T-cells against EBV
Daan Dierickx, UZ Leuven, Belgium
Satellite 2 – Gilead : Mantle cell lymphoma in 2022: challenges and opportunities
Chair: Marc André
Introduction
Marc André, CHU UCL Namur, Belgium
Mantle cell lymphoma in Belgium: state of affairs and unmet medical need
Sylvia Snauwaert, AZ Sint Jan Brugge-Oostende, Belgium
Implementing novel treatment strategies in mantle cell lymphoma
Sunil Iyengar, The Royal Marsden London, UK
Q&A
Ethics & Economy
Chair: Valerie Robin
Advance care planning in hematology patients
Thomas LeBlanc, Duke Cancer institute, Durham, North Carolina, US
Panel discussion
Valerie Robin, Grand Hôpital de Charleroi, Belgium
Laurent Knoops, UCL Saint-Luc, Belgium
Thomas LeBlanc, Duke Cancer institute, Durham, North Carolina, US
Pierre Strijckmans Lecture
Chairs: Marc André & Ann Janssens
Introduction
Dimitri Breems, ZNA, Belgium
AML diagnosis and treatment
Bob Löwenberg, Erasmus University Medical Center, Rotterdam, the Netherlands
Special Lecture 2
Chairs: Nicole Straetmans & Cécile Boulanger
Autoimmune hemolytic anemia for the hematologist
Marc Michel, Hôpital Henri-Mondor Paris-Est Créteil, France
Oral Abstracts
Chairs: Dimitri Breems & Marc André
Julien Devreux, de Duve Institute Brussels, Belgium
Stef Meers, AZ Klina Brasschaat, Belgium
Koen Debackere, KU Leuven / UZ Leuven, Belgium
Marie-Christiane Vekemans, UC Louvain, Belgium
Siska Blomme, AZ-Sint Jan Brugge, Belgium
Wouter De Brouwer, UZ Brussel, Belgium